Charlotte Jones-Burton

International consensus definitions of clinical trial outcomes for kidney failure: 2020

Adeera Levin, Rajiv Agarwal, William G. Herrington et al. · Kidney International · 2020 · 118 citations · Full text

Medicine, Nephrology, Dialysis +16

Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial

Josep M. Grinyó, María del Carmen Rial, Josefina Alberú et al. · American Journal of Kidney Diseases · 2016 · 109 citations · Full text

Medicine, Nephrology, Pharmacotherapy +16

Safety and Efficacy of Ezetimibe Added on to Rosuvastatin 5 or 10 mg Versus Up-Titration of Rosuvastatin in Patients With Hypercholesterolemia (the ACTE Study)

Harold Bays, Michael H. Davidson, Rachid Massaad et al. · The American Journal of Cardiology · 2011 · 74 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention

Stephan Windecker, Renato D. Lópes, Tyler Massaro et al. · Circulation · 2019 · 70 citations

Medicine, Cardiology, Pharmacotherapy +17

Safety and Efficacy of Ezetimibe Added to Atorvastatin Versus Up Titration of Atorvastatin to 40 mg in Patients ≥65 Years of Age (from the ZETia in the ELDerly [ZETELD] Study)

Franklin J. Zieve, Nanette K. Wenger, Ori Ben‐Yehuda et al. · The American Journal of Cardiology · 2009 · 49 citations

Pharmacy, Pharmacology, Pharmacotherapy +9